Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Colorcon
Cerilliant
Argus Health
AstraZeneca
Boehringer Ingelheim
Dow
Covington
Harvard Business School
Teva

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016954

« Back to Dashboard

NDA 016954 describes MICRONOR, which is a drug marketed by Janssen Pharms and is included in one NDA. It is available from three suppliers. Additional details are available on the MICRONOR profile page.

The generic ingredient in MICRONOR is norethindrone. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
Summary for 016954
Tradename:MICRONOR
Applicant:Janssen Pharms
Ingredient:norethindrone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 016954
Ingredient-typeProgesterone Congeners
Medical Subject Heading (MeSH) Categories for 016954
Suppliers and Packaging for NDA: 016954
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MICRONOR norethindrone TABLET;ORAL-28 016954 NDA Janssen Pharmaceuticals, Inc. 50458-194 50458-194-12 12 BLISTER PACK in 1 CARTON (50458-194-12) > 28 TABLET in 1 BLISTER PACK (50458-194-00)
MICRONOR norethindrone TABLET;ORAL-28 016954 NDA Janssen Pharmaceuticals, Inc. 50458-194 50458-194-16 6 BLISTER PACK in 1 CARTON (50458-194-16) > 28 TABLET in 1 BLISTER PACK (50458-194-00)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.35MG
Approval Date:Approved Prior to Jan 1, 1982TE:AB2RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Chubb
QuintilesIMS
Covington
AstraZeneca
Fuji
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot